Volatile Organic Compounds (VOCs) in human exhaled breath, though present in only trace concentrations (ppm or lower), can still hold significant clinical relevance. As an individual transitions from a healthy to a pathological state, their breath VOCs profile shifts in ways that can be detected and potentially used for disease detection and health monitoring [1]. Several studies have reported the use of VOC-based breath tests for the rapid and non-invasive detection of various diseases, including cirrhosis [2], asthma [3], colorectal cancer [4], and lung cancer [5]. We collected 30 exhaled breath samples from patients with various gastrointestinal conditions, which were then analyzed by Thermal Desorption-Gas Chromatography-Mass Spectrometry (TD-GC-MS).
The resulting data underwent pre-processing in order to generate a reliable data matrix for subsequent statistical analysis. The conventional approaches (involving denoising, baseline correction, alignment, peak picking, and data matrix construction) were compared to innovative chemometric techniques.
Beale D. J. et al., Int J Mol Sci, 18 (2017), pag. 1–26. DOI: 10.3390/ijms18010024.
Ferrandino G. et al., Clin Transl Gastroenterol, 11 (2020), pag. e00239. DOI: 10.14309/ctg.0000000000000239.
Schleich F. N. et al., Am J Respir Crit Care Med, 200 (2019), pag. 444–453. doi: 10.1164/rccm.201811-2210OC.
Altomare D. F. et al., BJS Open, 4 (2020), pag. 1189–1199. DOI: 10.1002/bjs5.50354.
Ratiu I. A. et al., J Clin Med, 10 (2021), pag. 1–41. DOI: 10.3390/jcm10010032.